Analytical Data
-
基因名
FGF13
- Application
-
别名
FGF13；FHF2；Fibroblast growth factor 13
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q92913
-
表达区间
1-245aa
-
氨基酸序列
MAAAIASSLI RQKRQARERE KSNACKCVSS PSKGKTSCDK NKLNVFSRVK LFGSKKRRRR RPEPQLKGIV TKLYSRQGYH LQLQADGTID GTKDEDSTYT LFNLIPVGLR VVAIQGVQTK LYLAMNSEGY LYTSELFTPE CKFKESVFEN YYVTYSSMIY RQQQSGRGWY LGLNKEGEIM KGNHVKKNKP AAHFLPKPLK VAMYKEPSLH DLTEFSRSGS GTPTKSRSVS GVLNGGKSMS HNEST
-
分子量
28 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Fibroblast growth factor 13 (FGF13) is a member of the fibroblast growth factor family, which plays crucial roles in various biological processes, including cell proliferation, differentiation, and survival. Unlike other FGFs, FGF13 is primarily expressed in the brain and heart, where it has been implicated in neuronal development and cardiac function. Recent studies have highlighted its potential involvement in neuroprotective mechanisms and cardiac arrhythmias, making it a significant focus for research in neurobiology and cardiology. The recombinant production of FGF13 proteins is essential for elucidating their structural and functional properties, as well as for exploring their therapeutic potential. Understanding how FGF13 interacts with its receptors and other cellular pathways is vital for developing strategies to mitigate diseases linked to its dysfunction, such as neurodegenerative disorders and heart diseases. Therefore, generating purified FGF13 recombinant proteins is a critical step toward advancing our understanding of its biological roles and therapeutic applications.
